Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The current state and future directions of the field that studies the connection between the mind and skin are discussed.

Clomipramine may significantly reduce hair-pulling in Trichotillomania, but more research is needed on treatments and early onset cases.

Less attractive male venture capitalists take more risks influenced by entrepreneurs' looks, while more attractive ones are generally risk-tolerant.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.

Congenital triangular alopecia and vitiligo can occur together, but treatment for one may not affect the other.

Bald men are often viewed more negatively and as older than they really are.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Cantú syndrome may be linked to pituitary adenomas.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Platelet-rich plasma therapy might help treat some kinds of hair loss.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

DPCP can help regrow hair in some people with severe alopecia.

Ruxolitinib treatment may cause eyelash growth.

Pityriasis rubra pilaris is a rare skin disorder with reddish-orange patches and thickened skin, needing better treatment understanding.

Bimatoprost can cause excessive eyelash growth.

Quetiapine may cause hair loss.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Two southern chamois in the Eastern Pyrenees had skin infections caused by a fungus.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Early diagnosis of Keratosis pilaris atrophicans faciei can lead to better, personalized treatments.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Men with hair loss and shorter height may be perceived as less attractive.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

A rare biotin deficiency in an Iraqi family caused severe symptoms but was successfully treated with lifelong biotin.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Tofacitinib taken by mouth helps treat hair loss in children.